Joseph G. Pressey · Molecular pathogenesis of rhabdomyosarcoma
Follow
Article1 min read·Published Jan 2002Older

Molecular pathogenesis of rhabdomyosarcoma

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2002 · 1 min read

In brief

In brief

This article reviews the molecular mechanisms underlying rhabdomyosarcoma subtypes in pediatric patients. Alveolar RMS features PAX-FKHR fusion proteins from chromosomal translocations, while embryonal RMS involves chromosome 11p15.5 loss, with both subtypes showing alterations in p53 and RB pathways through distinct genetic mechanisms.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Rhabdomyosarcoma (RMS) is a family of soft tissue tumors that are associated with the skeletal muscle lineage and generally occur in the pediatric population. Based on histopathologic features, two subtypes, embryonal (ERMS) and alveolar (ARMS), were identified and associated with distinct clinical characteristics and genetic alterations. ARMS is associated with 2;13 or 1;13 chromosomal translocations, which generate PAX3-FKHR and PAX7-FKHR fusion products, respectively. These translocations result in altered expression, function, and subcellular localization of the fusion products relative to the wild-type proteins, and ultimately contribute to oncogenic behavior by modifying growth, differentiation, and apoptosis pathways. In contrast to the specific translocations found in ARMS, most ERMS cases have allelic loss at chromosome 11p15.5. Chromosome fragment transfer studies demonstrated that this region represses tumor cell growth, suggesting the presence of tumor suppressor gene(s) in this region. In both ERMS and ARMS, there is evidence of collaborating alterations that affect common targets, such as the p53 and RB pathways. One mechanism for perturbing these pathways involves amplification of genes such as MDM2 and CDK4; these amplification events occur frequently in ARMS but only rarely in ERMS. Therefore, despite similarities in the downstream targets of these genetic alterations, the striking cytogenetic and molecular differences between ARMS and ERMS indicate distinct

Statements in this article

  1. Rhabdomyosarcoma is a family of soft tissue tumors associated with the skeletal muscle lineage and generally occurs in the pediatric population.

    Established
  2. Two histopathologic subtypes of rhabdomyosarcoma are embryonal (ERMS) and alveolar (ARMS), which are associated with distinct clinical characteristics and genetic alterations.

    Established
  3. Alveolar rhabdomyosarcoma is associated with 2;13 or 1;13 chromosomal translocations, which generate PAX3-FKHR and PAX7-FKHR fusion products, respectively.

    Research
  4. PAX3-FKHR and PAX7-FKHR translocations result in altered expression, function, and subcellular localization of the fusion products relative to wild-type proteins.

    Research
  5. PAX-FKHR fusion products contribute to oncogenic behavior by modifying growth, differentiation, and apoptosis pathways.

    Research
  6. Most embryonal rhabdomyosarcoma cases have allelic loss at chromosome 11p15.5.

    Research
  7. Chromosome fragment transfer studies demonstrated that the 11p15.5 region represses tumor cell growth, suggesting the presence of tumor suppressor gene(s) in this region.

    Research
  8. In both embryonal and alveolar rhabdomyosarcoma, there is evidence of collaborating alterations that affect common targets, such as the p53 and RB pathways.

    Research
  9. Amplification of genes such as MDM2 and CDK4 occurs frequently in alveolar rhabdomyosarcoma but only rarely in embryonal rhabdomyosarcoma.

    Research
  10. The striking cytogenetic and molecular differences between alveolar and embryonal rhabdomyosarcoma indicate distinct pathogenic mechanisms despite similarities in downstream targets.

    Research

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.